These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12505406)

  • 21. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine.
    Minke JM; Toulemonde CE; Dinic S; Cozette V; Cullinane A; Audonnet JC
    J Comp Pathol; 2007 Jul; 137 Suppl 1():S76-80. PubMed ID: 17559865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of equine influenza vaccines for protection against A/Equine/Jilin/89 (H3N8)--a new equine influenza virus.
    Webster RG; Thomas TL
    Vaccine; 1993; 11(10):987-93. PubMed ID: 8212831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain.
    Nemoto M; Yamayoshi S; Bannai H; Tsujimura K; Kokado H; Kawaoka Y; Yamanaka T
    Arch Virol; 2019 Sep; 164(9):2355-2358. PubMed ID: 31227892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines.
    Mumford JA; Jessett DM; Rollinson EA; Hannant D; Draper ME
    Vet Rec; 1994 Feb; 134(7):158-62. PubMed ID: 8160328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
    Ryan M; Gildea S; Walsh C; Cullinane A
    Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.
    Lunn DP; Hussey S; Sebing R; Rushlow KE; Radecki SV; Whitaker-Dowling P; Youngner JS; Chambers TM; Holland RE; Horohov DW
    J Am Vet Med Assoc; 2001 Mar; 218(6):900-6. PubMed ID: 11294315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for immunity against equine influenza virus infections.
    Bürki F; Lamatsch O
    Comp Immunol Microbiol Infect Dis; 1981; 4(3-4):267-78. PubMed ID: 6174266
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
    Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
    Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine.
    Heldens JG; Kersten AJ; Weststrate MW; van den Hoven R
    Vet Q; 2001 Nov; 23(4):210-7. PubMed ID: 11765243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficiency of equine influenza vaccines including tetanus toxoid of combined vaccines].
    Bommeli W; Kihm U; Löhrer J; Fey H
    Schweiz Arch Tierheilkd; 1980 Jan; 122(1):27-37. PubMed ID: 7384775
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field observations on influenza vaccination among horses in Britain, 1971-1976.
    Powell DG; Burrows R; Spooner P; Mumford J; Thomson G
    Dev Biol Stand; 1977 Jun 1-3; 39():347-52. PubMed ID: 604119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study.
    Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S
    Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equine influenza vaccine efficacy: the significance of antigenic variation.
    Yates P; Mumford JA
    Vet Microbiol; 2000 May; 74(1-2):173-7. PubMed ID: 10799789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equine influenza immunisation--the role of nasal antibody--a review.
    Rouse BT
    Aust Vet J; 1971 Apr; 47(4):146-8. PubMed ID: 4931390
    [No Abstract]   [Full Text] [Related]  

  • 38. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination.
    Soboll G; Horohov DW; Aldridge BM; Olsen CW; McGregor MW; Drape RJ; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2003 Jul; 94(1-2):47-62. PubMed ID: 12842611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against equine herpesvirus 1 and equine influenza infection.
    Witherspoon DM
    Vet Rec; 1984 Oct; 115(14):363. PubMed ID: 6093330
    [No Abstract]   [Full Text] [Related]  

  • 40. ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse.
    Paillot R; Prowse L
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):516-21. PubMed ID: 22178272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.